SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001387131-20-010608
Filing Date
2020-12-08
Accepted
2020-12-08 16:20:29
Documents
1
Group Members
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND II, L.P.DECHENG CAPITAL GLOBAL HEALTHCARE FUND (MASTER), LPDECHENG CAPITAL GLOBAL HEALTHCARE GP, LLCDECHENG CAPITAL MANAGEMENT II (CAYMAN), LLCDECHENG CAPITAL MANAGEMENT III (CAYMAN), LLCXIANGMIN CUI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13D bysi-sc13da_112320.htm SC 13D/A 233992
  Complete submission text file 0001387131-20-010608.txt   235858
Mailing Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005
Business Address 28 LIBERTY STREET 39TH FLOOR NEW YORK NY 10005 646-528-4184
BeyondSpring Inc. (Subject) CIK: 0001677940 (see all company filings)

IRS No.: 463009483 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90237 | Film No.: 201375539
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 345-949-8066
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by) CIK: 0001736814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A